Latanoprost 0.005% Ophthalmic Solution: Indication
Latanoprost 0.005% ophthalmic solution is used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. 1
Primary Indication
This medication treats two main conditions:
- Open-angle glaucoma - a chronic progressive eye disease that damages the optic nerve and can lead to irreversible blindness if untreated
- Ocular hypertension - elevated pressure inside the eye that increases risk of developing glaucoma
How It Works
Latanoprost is a prostaglandin analog that reduces intraocular pressure by increasing uveoscleral outflow (the drainage of fluid from the eye). 2 The medication begins lowering pressure approximately 3-4 hours after administration, with maximum effect reached at 8-12 hours. 1
Dosing and Administration
The standard dose is one drop in the affected eye(s) once daily in the evening. 1 Key administration points include:
- Do not exceed once-daily dosing - more frequent administration may paradoxically decrease effectiveness or even elevate IOP 1
- If using multiple eye drops, wait at least 5 minutes between medications 1
- Remove contact lenses before administration; may reinsert after 15 minutes 1
Position in Treatment Guidelines
Prostaglandin analogs like latanoprost are the most frequently prescribed initial therapy for glaucoma because they are highly efficacious, well-tolerated, and require only once-daily dosing. 3 Among first-line medications, latanoprost ranks among the most effective agents, though bimatoprost shows slightly superior IOP reduction while latanoprost has the most favorable tolerability profile. 4
Efficacy Evidence
Clinical trials demonstrate that latanoprost 0.005% once daily:
- Reduces diurnal IOP by 22-39% over 1-12 months of treatment 2
- Is more effective than timolol 0.5% twice daily in most comparative studies 2
- Shows equivalent efficacy to other prostaglandin analogs (bimatoprost, travoprost) 4
- Provides superior IOP lowering compared to dorzolamide, brimonidine, or unoprostone 2
Common Side Effects to Anticipate
The most frequent adverse effects are ocular and generally mild to moderate:
- Conjunctival hyperemia (eye redness) - 3-15% of patients 2
- Iris pigmentation changes - gradual browning of the iris that may be permanent (2-9%) 1, 2
- Eyelash changes - increased length, thickness, and pigmentation (usually reversible) 1
- Eye pain and irritation - particularly in initial weeks 5
Important caveat: Unlike beta-blockers (like timolol), latanoprost produces minimal systemic cardiovascular or respiratory side effects, making it safer for patients with asthma, COPD, or cardiac conditions. 2
Preservative-Free Formulations
Preservative-free latanoprost formulations are available and offer advantages for patients with:
- Ocular surface disease
- Sensitivity to benzalkonium chloride (BAK)
- Need for long-term therapy
- Planned future glaucoma surgery
These formulations provide equivalent IOP-lowering efficacy with improved ocular surface tolerability. 5, 6, 7